A diagnostic cohort study on the accuracy of 18-fluorodeoxyglucose (18FDG) positron emission tomography (PET)-CT for evaluation of malignancy in anterior mediastinal lesions: the DECiMaL study.

Loading...
Thumbnail Image
Authors
Proli, C.
De Sousa, P.
Jordan, S.
Anikin, V.
Devaraj, A.
Love, S. M.
Shackcloth, M.
Kostoulas, N.
Papagiannopoulos, K.
Haqzad, Y.
Journal
BMJ open
Type
Journal Article
Publisher
BMJ
Rights
Archived with thanks to BMJ open. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/ licenses/by-nc/4.0/
The aim of this study is to collate multi-institutional data to determine the value by defining the diagnostic performance of fluorodeoxyglucose positron emission tomography (FDG PET)/CT for malignancy in patients undergoing surgery with an anterior mediastinal mass in order to ascertain the clinical utility of PET/CT to differentiate malignant from benign aetiologies in patients presenting with an anterior mediastinal mass SETTING: DECiMaL Study is a multicentre, retrospective, collaborative cohort study in seven UK surgical sites.
Citation
A diagnostic cohort study on the accuracy of 18-fluorodeoxyglucose (18FDG) positron emission tomography (PET)-CT for evaluation of malignancy in anterior mediastinal lesions: the DECiMaL study. 2018, 8 (2):e019471 BMJ Open
Note
This article is freely available via Open Access. Click on the Additional Link above to access the full-text via the publisher's site.